Clincosm LogoSign in Get a demo

Dyslipidemias

Showing 26 - 50 of 300
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias Trial (Guideline directed statin therapy, High intensity statin

Not yet recruiting
  • Coronary Artery Calcification
  • +2 more
  • Guideline directed statin therapy
  • High intensity statin plus ezetimibe therapy
  • (no location specified)
Apr 25, 2023

Dyslipidemias Trial (DKP21102_C, DKP21102_B, DKP21102_A)

Not yet recruiting
  • Dyslipidemias
  • (no location specified)
Apr 12, 2023

PreDiabetes, Abdominal Obesity, Hypertension Trial in Beijing (Berberine plus lifestyle intervention, Placebo plus lifestyle

Not yet recruiting
  • PreDiabetes
  • +3 more
  • Berberine plus lifestyle intervention
  • Placebo plus lifestyle intervention
  • Beijing, China
    Fuwai Hospital, Chinese Academy of Medical Sciences, National Ce
Mar 6, 2023

Diabetes, Type 2, Dyslipidemias, Hypertension Trial in Cairo (Puritans Pride Turmeric curcumin® 500 mg)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Puritans Pride Turmeric curcumin® 500 mg
  • Cairo, Egypt
    Demerdash Hospital, Faculty of Medicine, Ain Shams University
Mar 1, 2023

Insulin Resistance, Hyperinsulinemia, Dyslipidemias Trial in New York (drug, device, diagnostic test, dietary supplement)

Recruiting
  • Insulin Resistance
  • +2 more
  • Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 3, 2023

Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)

Not yet recruiting
  • Dyslipidemias
  • Atherosclerotic Cardiovascular Disease
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jan 29, 2023

Obesity, Prediabetic State, Dyslipidemias Trial (INOSITOLS, CELLULOSE)

Not yet recruiting
  • Obesity
  • +3 more
  • INOSITOLS
  • CELLULOSE
  • (no location specified)
Jan 19, 2023

Dyslipidemias, Obesity Trial in Storrs (Milk Polar Lipid-Rich Dairy Powder, Dairy Powder)

Not yet recruiting
  • Dyslipidemias
  • Obesity
  • Milk Polar Lipid-Rich Dairy Powder
  • Dairy Powder
  • Storrs, Connecticut
    University of Connecticut
Jan 18, 2023

Dyslipidemias Trial in Australia, New Zealand (ARO-APOC3)

Enrolling by invitation
  • Dyslipidemias
  • Beverly Hills, California
  • +36 more
Jan 13, 2023

Obesity, Dyslipidemias Trial in Rio de Janeiro (Evaluation of systemic skin microvascular endothelial function)

Completed
  • Obesity
  • Dyslipidemias
  • Evaluation of systemic skin microvascular endothelial function
  • Rio de Janeiro, Brazil
    National Institute of Cardiology
Jan 17, 2023

Dyslipidemias, Overweight and Obesity, Nutrition, Healthy Trial in Athens (CSO LOW, CSO MID, CSO HIGH)

Recruiting
  • Dyslipidemias
  • +2 more
  • CSO LOW
  • +3 more
  • Athens, Georgia
    University of Georgia
Jan 13, 2023

Psychosocial, Environmental, and Chronic Disease Trends in

Recruiting
  • Heart Diseases
  • +14 more
    • San Juan, Puerto Rico
      FDI Clinical Research
    Dec 23, 2022

    Metabolic Syndrome, Obesity, Dyslipidemias Trial in Birmingham (Carbohydrate restricted group, Standard low fat diet)

    Completed
    Has Results
    • Metabolic Syndrome
    • +2 more
    • Carbohydrate restricted group
    • Standard low fat diet
    • Birmingham, Alabama
    • +1 more
    Nov 29, 2022

    OLOMAX for Blood Pressure and Low-density Lipoprotein

    Recruiting
    • Hypertension
    • Dyslipidemias
    • Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca
    • Seoul, Korea, Republic of
      Seoul St.Mary's Hospital
    Dec 13, 2022

    CARDIOMETABOLIC CONDITIONS, Obesity, Pre-diabetes Trial in Chicago, Saint Louis, Pittsburgh (Base intervention, Augmented

    Not yet recruiting
    • CARDIOMETABOLIC CONDITIONS
    • +6 more
    • Base intervention
    • Augmented Intervention
    • Chicago, Illinois
    • +2 more
    Dec 8, 2022

    Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Placebo, Obicetrapib)

    Recruiting
    • Dyslipidemias
    • +4 more
    • Anniston, Alabama
    • +126 more
    Dec 8, 2022

    Hypertension, Diabetes, Dyslipidemias Trial in Beijing (No intervention)

    Recruiting
    • Hypertension
    • +2 more
    • No intervention
    • Beijing, Beijing, China
      Beijing Tongren Hospital
    Dec 8, 2022

    Dyslipidemias, Hypertension Trial in Georgia, Russian Federation, Ukraine (Atorvastatin/Perindopril, Atorvastatin, Perindopril)

    Terminated
    • Dyslipidemias
    • Hypertension
    • Kutaisi, Georgia
    • +41 more
    Dec 2, 2022

    Dyslipidemias Trial in Seoul (Drug: CKD-391, QD, PO)

    Not yet recruiting
    • Dyslipidemias
    • Drug: CKD-391, QD, PO
    • Seoul, Gangseo-gu, Korea, Republic of
      Bumin Hospital(Seoul)
    Nov 22, 2022

    Metabolic Syndrome, High Blood Pressure, High Cholesterol Trial in Wilrijk (Tensiofytol, Cholesfytol NG, Placebo)

    Recruiting
    • Metabolic Syndrome
    • +4 more
    • Tensiofytol
    • +2 more
    • Wilrijk, Belgium
      UAntwerp, NatuRA
    Nov 22, 2022

    Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman

    Not yet recruiting
    • Dyslipidemias
    • Atherosclerotic Cardiovascular Disease
      • Amman, Jordan
      • +1 more
      Nov 23, 2022

      Dyslipidemias Trial in Samara (Combined Lipid-lowering Therapy)

      Recruiting
      • Dyslipidemias
      • Combined Lipid-lowering Therapy
      • Samara, Russian Federation
        Samara Regional Cardiology Dispansery
      Nov 17, 2022

      Cardiovascular Diseases, Atherosclerosis, Dyslipidemias Trial (Digitally-enabled Multifaceted Quality Improvement Intervention,

      Not yet recruiting
      • Cardiovascular Diseases
      • +2 more
      • Digitally-enabled Multifaceted Quality Improvement Intervention
      • Usual care
      • (no location specified)
      Nov 14, 2022

      Hypertension, Adult, Dyslipidemias Trial in Kumasi, Zaria, Ibadan (Riskometer Application, Routine Clinic Therapy)

      Recruiting
      • Hypertension
      • +5 more
      • Riskometer Application
      • Routine Clinic Therapy
      • Kumasi, Ghana
      • +2 more
      Nov 15, 2022

      Status of Dyslipidemia Following Administration of Statin and

      Recruiting
      • Dyslipidemias
      • Statin+Ezetimibe compound
      • Seoul, Korea, Republic of
        Korea University Guro Hospital
      Nov 7, 2022